Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director, 10%+ Owner
-
Stock Symbol
-
ALZN on Nasdaq
Milton C. Ault III - trading volume in the past year for Alzamend Neuro, Inc.
Holdings reported by Milton C. Ault III for Alzamend Neuro, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
99.6K |
$68.6K |
$0.69 |
Aug 6, 2024 |
By Ault Life Sciences, Inc. |
|
|
| Common Stock |
77.3K |
$53.2K |
$0.69 |
Aug 6, 2024 |
By Ault Lending, LLC |
|
|
| Common Stock |
16.7K |
$11.5K |
$0.69 |
Aug 6, 2024 |
Direct |
|
|
| Common Stock |
549 |
$378 |
$0.69 |
Aug 6, 2024 |
By Ault Life Sciences Fund, LLC |
|
|
| Warrants |
2M |
|
|
Mar 26, 2024 |
By Ault Lending, LLC |
Common Stock |
|
| Series B Convertible Preferred Stock |
2K |
|
|
Mar 26, 2024 |
By Ault Lending, LLC |
Common Stock |
|
| Series A Convertible Preferred Stock |
1.22K |
|
|
Jan 31, 2024 |
By Ault Life Sciences Fund, LLC |
Common Stock |
|
Transactions reported by Milton C. Ault III for Alzamend Neuro, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.